awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36356058-87734A2F-A8F1-4AE6-B47E-D9EC35056B07
Q36356058-87734A2F-A8F1-4AE6-B47E-D9EC35056B07
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36356058-87734A2F-A8F1-4AE6-B47E-D9EC35056B07
A retrospective analysis of cisplatin, pemetrexed, and bevacizumab in previously treated non-small-cell lung cancer
P2860
Q36356058-87734A2F-A8F1-4AE6-B47E-D9EC35056B07
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36356058-87734A2F-A8F1-4AE6-B47E-D9EC35056B07
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
2bcb7bad9da249f8d7c9162128241a855381ad1c
P2860
FDA drug approval summary: bevacizumab (Avastin) plus Carboplatin and Paclitaxel as first-line treatment of advanced/metastatic recurrent nonsquamous non-small cell lung cancer.